FAKTOR OPTIONSSCHEIN - ELANCO ANIMAL HEALTH Share Price

Certificat

DE000PE5ELA4

Delayed Deutsche Boerse AG 01:20:22 22/05/2024 am IST
0.09 EUR -9.09% Intraday chart for FAKTOR OPTIONSSCHEIN - ELANCO ANIMAL HEALTH
Current month+95.65%
1 month+114.29%
Date Price Change
21/24/21 0.09 -9.09%
20/24/20 0.099 -1.98%
17/24/17 0.101 +3.06%
16/24/16 0.098 -2.00%
15/24/15 0.1 +1.01%

Delayed Quote Deutsche Boerse AG

Last update May 22, 2024 at 01:20 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ELANCO ANIMAL HEALTH INCORPORATED
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE5ELA
ISINDE000PE5ELA4
Date issued 02/06/2022
Strike 17 $
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 57.43
Lowest since issue 0.02
Spread 0.003
Spread %3.30%

Company Profile

Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Sector
-
More about the company

Ratings for Elanco Animal Health Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Elanco Animal Health Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
16.7 USD
Average target price
19.11 USD
Spread / Average Target
+14.46%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW